Gene:
BRCA1
breast cancer 1, early onset

PharmGKB contains no dosing guidelines for this gene. To report known dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this gene. To report a drug label with PGx, click here.

PharmGKB contains no clinical annotations for this gene. To report clinical variants, click here.

PharmGKB contains no genetic tests for this gene. To report genetic tests, click here.

The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.

The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page.

Links in the "Drugs" column lead to PharmGKB Drug Pages.

Variant?
(build 132)
Alternate Names ? Drugs ? Alleles ? Function ? Amino Acid?
Translation
VIP No Clinical Annotations available No Variant Annotations available
chr17:41276046
VIP No Clinical Annotations available No Variant Annotations available
chr17:41209080
Alleles, Functions, and Amino Acid Translations are all sourced from dbSNP build 132

Overview

Alternate Names:  BRCA1/BRCA2-containing complex, subunit 1; OTTHUMP00000212147; OTTHUMP00000212148; OTTHUMP00000212149; OTTHUMP00000212150; OTTHUMP00000212151; OTTHUMP00000212155; RING finger protein 53; breast and ovarian cancer susceptibility protein 1; breast and ovarian cancer sususceptibility protein; breast cancer type 1 susceptibility protein; breast-ovarian cancer, included
Alternate Symbols:  BRCAI; BRCC1; BROVCA1; IRIS; PNCA4; PSCP; RNF53
Haplotypes: BRCA1 1; BRCA1 1#; BRCA1 2; BRCA1 2#; BRCA1 3; BRCA1 3#; BRCA1 4; BRCA1 4#; BRCA1 5; BRCA1 5#; BRCA1 6; BRCA1 7; BRCA1 8; BRCA1 9; BRCA1 10
PharmGKB Accession Id: PA25411

Details

Cytogenetic Location: chr17 : q21.31 - q21.31
GP mRNA Boundary: chr17 : 41196314 - 41277468
GP Gene Boundary: chr17 : 41193314 - 41287468
Strand: minus
Product Name: breast and ovarian cancer susceptibility protein, breast and ovarian cancer susceptibility protein 1, breast and ovarian cancer suseptibility protein variant, breast cancer 1, early onset, breast cancer 1, early onset isoform 1, breast cancer 1, early onset isoform BRCA1-delta11, breast cancer 1, early onset isoform BRCA1-delta11b, breast cancer 1, early onset isoform BRCA1-delta14-17, breast cancer 1, early onset isoform BRCA1-delta14-18, breast cancer 1, early onset isoform BRCA1-delta15-17, breast cancer 1, early onset isoform BRCA1-delta2-10, breast cancer 1, early onset isoform BRCA1-delta9-10, breast cancer 1, early onset isoform BRCA1-delta9-10-11b, breast cancer 1, early onset isoform BRCA1-delta9-11, breast cancer 1, early onset isoform BRCA1-exon4
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

All alleles are displayed on the positive chromosomal strand.

Download Haplotype Data (CSV)

Haplotype rs1060915 rs12516 rs16940 rs16941 rs16942 rs17599948 rs1799949 rs1799966 rs3092995 rs4986850 rs4986852 rs799912 rs799917 rs8176318 rs9908805 rs9911630
BRCA1 1 A G A T T A G T C C C C G C T G
BRCA1 1# G G A T T A G T C C C C G C T G
BRCA1 2 G G G C C A A C C C C C A C T G
BRCA1 2# G G A T T G G T C C C C G C T G
BRCA1 3 G G A T T A G C C C C C G C T G
BRCA1 3# G G A T T A G T C C C C G A T G
BRCA1 4 A G A T T A G T C C C C G C T G
BRCA1 4# G G A T T G G T C C C C G A T G
BRCA1 5 A G A T T A G T C C T C G C T G
BRCA1 5# G A A T T G G T C C C T G A T G
BRCA1 6 G G G C C A A C C T C C A C T G
BRCA1 7 G G G C C A A C C T C C A C T G
BRCA1 8 A G A T T A G T C C C C A C T G
BRCA1 9 A G A T C A A C C C C C A C T G
BRCA1 10 G G A C T A G C C C C C G C T G

No related genes are available.

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other genes is available.

Curated Information ?

Drug Relationship Evidence
caffeine
  • PD
  •   
Publications
cisplatin
  • PD
  •   
Publications
mifepristone
  •   
  •   
Publications
tamoxifen
  •   
  •   
Publications

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other drugs is available.

Curated Information ?

Disease Relationship Evidence
Breast Neoplasms
  • PD
  •   
Publications, Variants
Breast Neoplasms, Male
  •   
  •   
Publications
Colonic Neoplasms
  •   
  •   
Publications
Fallopian Tube Neoplasms
  •   
  •   
Publications
Hereditary Breast/Ovarian Cancer Syndrome
  •   
  •   
Publications
Neoplasms
  •   
  •   
Publications, Variants
Ovarian Neoplasms
  • PD
  •   
Publications
Pancreatic Neoplasms
  •   
  •   
Publications
Prostatic Neoplasms
  •   
  •   
Publications
Stomach Neoplasms
  •   
  •   
Publications
Uterine Cervical Neoplasms
  •   
  •   
Publications
Uterine Neoplasms
  •   
  •   
Publications

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other diseases is available.

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.